CBD has been shown to have some of the most impressive and well-published results in reducing frequency, intensity, or duration of seizures. In some reports, seizures stopped completely and CBD displayed powerful anticonvulsant properties. Epidiolex is a patented pharmaceutical made from cannabidiol (CBD) and is prescribed for Lennox-Gastuat and Dravet syndromes.
- Smith, Gregory, L. Cannabidiol (CBD). What you need to know. 2017.
- Cilio, Maria, R. The case for assessing cannabidiol in epilepsy. Epilespia. 55(6): 787-790. 2014. (https://pubmed.ncbi.nlm.nih.gov/24854434/)
- Leo, Antonio, et al. Cannabidiol and epilepsy: rationale and therapeutic potential. Pharmacological Research. 107: 85-92. 2016. (https://pubmed.ncbi.nlm.nih.gov/26976797/)
- Pamplona, F. A. et al. Potential clinical benefits of CBD-rich cannabis extracts over purified CBD in treatment-resistant epilepsy: observational data meta-analysis. Frontiers in Neurology. 9(759): 1-9. 2018. (https://pubmed.ncbi.nlm.nih.gov/30258398/)
- Perucca, Emilio. Cannabinoids in the treatment of epilepsy? Hard evidence at last? Journal of Epilepsy Research. 7(2): 61-76. 2017. (https://pubmed.ncbi.nlm.nih.gov/29344464/)